Venture Studios de-risks venture investments by pulling business ideas from within their own network of resources & partner organizations and assigns internal and external teams to develop ‘NewCos’ and make them commercially viable.
Our bespoke innovation roundtables, in collaboration with our multinational partners, provide insights into the most critial problems facing their respective verticals. We then develop solutions / NewCo’s to be deployed in their ready-made channels.
GAV Partnered with Pacira BioSciences, Inc. (NASDAQ: PCRX) to create C4AT, the first Think Tank / Venture Studio to combat the opioid epidemic in the US. Pacira develops and distributes Experel®, a non-opioid based analgesic which is shaking up the market. C4AT is proving thought leadership for better patient outcomes, changing public policy, and develop new applications to disrupt the opioid industry.
We took our program to London & NYC and started GAV FinTech Venture Studio. We paired this with the London Stock Exchange’s private company development program ELITE www.lseg.com/elite and have onboarded some of the most promising and ambitious companies in the Tri-State area to include three GAV portfolio companies
In 2020 GAV is launching the most progressive, impact focused Venture Studios with some of the most lauded Research Institutions on the planet. We will be announcing our partnerships in a broad communications campaign in short order. Make sure you sign up for our newsletter !